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Introduction
Genome-wide association studies have identified common obesity variants that map at over 100 loci 
across the genome (1). Our aim is to deconvolute the strongest genetic signal for adiposity within an ~47-
kb interval in the first intron of  α-ketoglutarate–dependent dioxygenase gene (FTO). Specific noncoding 
alleles within this interval are associated with ~3.5-pound and ~2-pound body weight differences, per risk 
allele, in adults and children, respectively (2–6). Two of  the associated single nucleotide polymorphisms 
Intronic polymorphisms in the α-ketoglutarate–dependent dioxygenase gene (FTO) that are 
highly associated with increased body weight have been implicated in the transcriptional 
control of a nearby ciliary gene, retinitis pigmentosa GTPase regulator-interacting protein-1 like 
(RPGRIP1L). Previous studies have shown that congenital Rpgrip1l hypomorphism in murine 
proopiomelanocortin (Pomc) neurons causes obesity by increasing food intake. Here, we show by 
congenital and adult-onset Rpgrip1l deletion in Pomc-expressing neurons that the hyperphagia and 
obesity are likely due to neurodevelopmental effects that are characterized by a reduction in the 
Pomc/Neuropeptide Y (Npy) neuronal number ratio and marked increases in arcuate hypothalamic–
paraventricular hypothalamic (ARH-PVH) axonal projections. Biallelic RPGRIP1L mutations result 
in fewer cilia-positive human induced pluripotent stem cell–derived (iPSC-derived) neurons and 
blunted responses to Sonic Hedgehog (SHH). Isogenic human ARH-like embryonic stem cell–
derived (ESc-derived) neurons homozygous for the obesity-risk alleles at rs8050136 or rs1421085 
have decreased RPGRIP1L expression and have lower numbers of POMC neurons. RPGRIP1L 
overexpression increases POMC cell number. These findings suggest that apparently functional 
intronic polymorphisms affect hypothalamic RPGRIP1L expression and impact development of 
POMC neurons and their derivatives, leading to hyperphagia and increased adiposity.
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(SNPs), rs8050136 and rs1421085, alter DNA-binding of  CUX1 (7, 8), a transcription factor involved in 
neurodevelopment and highly expressed in the arcuate hypothalamus (ARH) (7, 9, 10).9. In the CNS, 
CUX1 regulates the expression of  FTO and 5′-adjacent RPGRIP1L (7, 8, 11) encoding a protein located 
at the transition zone of  the primary cilium (12). Gene mutations in components of  the primary cilium 
cause syndromic and nonsyndromic forms of  obesity, such as Bardet-Biedl Syndrome (BBS), Alström, 
tubby (13–15), and MC4R/AC3 (16). The subcellular localization of  RPGRIP1L at the gate between 
cytoplasm and cilium suggests it may regulate entry and exit of  ciliary signaling components relating to 
energy balance. In support of  this hypothesis, the leptin receptor long isoform (Lepr-b) colocalizes with 
RPGRIP1L (17). We have also reported that Rpgrip1l expression is downregulated in the hypothalamus 
of  leptin-deficient mice and is upregulated by leptin administration (11), indicating that RPGRIP1L may 
convey anorectic effects via the canonical leptin signaling pathway. Mice with congenital systemic dele-
tion of  1 Rpgrip1l copy, or 2 Rpgrip1l copies in leptin-receptor isoform b-expressing neurons, are hyper-
phagic, obese, and display diminished suppression of  food intake in response to leptin administration (8, 
17). Hence, it is possible that RPGRIP1L modulates food intake in adults through cilia-dependent regula-
tion of  Lepr-b trafficking and function.
Embryonic lethality due to Rpgrip1l global deletion in mice is accompanied by severe CNS abnor-
malities of  the cerebellar vermis and midbrain, as well as dilation of  ventricles (18, 19). Consistent with 
phenotypic effects in the CNS, Rpgrip1l hypomorphism in the developing cerebral cortex impairs neu-
ronal migration (20). In humans, RPGRIP1L mutations in Joubert Syndrome (JBST) cause “the molar 
tooth” characterized by cerebral vermian hypoplasia, accompanied by elongation of  the caudal tegmen-
tum and dysplasia of  the caudal medulla (19). The severity of  developmental defects in individuals who 
lack functional RPGRIP1L may mask a potential role in energy homeostasis. However, a recent report 
described a JBST patient with mutations in ciliary adenosine diphosphate (ADP) ribosylation factor–
like GTPase 13B (ARL13B) who presented with obesity and structural brain abnormalities similar to 
those individuals with RPGRIP1L inactivating mutations (21), suggesting that anatomical/functional 
CNS abnormalities caused by RPGRIP1L haploinsufficiency may cause obesity in humans.
Loss of  RPGRIP1L in human primary cell cultures and mice results in increased ciliary axonemal 
length (17, 22), and systemic overexpression of  Cux1 in mice increases cilia length and causes polycystic 
kidney disease, a typical ciliopathic phenotype (23). Collectively, these reports suggest that RPGRIP1L 
and CUX1 may be part of  the same cilia-related pathway. Moreover, CUX1 loss of  function affects 
aspects of  cortical neurocircuit assembly of  the corpus callosum (9, 10). Given the observed CNS and 
ciliary anatomical changes caused by alterations in RPGRIP1L and CUX1 expression, we hypothesized 
that CUX1-dependent transcriptional control of  RPGRIP1L may account for some of  the association of  
FTO intronic SNPs with adiposity by modulating regulation of  food intake via cilia-dependent alterations 
of  hypothalamic structure.
Results
Induction of Rpgrip1l hypomorphism in the adult ARH causes obesity 
Arcuate stereotaxic injections. Mice segregating for 1 congenital null Rpgrip1l allele systemically (Rpgrip1l+/–) 
ingest more regular chow as early as 4 weeks of  age and display increased adiposity by 12 weeks of  age (17). 
Just as in congenital Rpgrip1l hypomorphism, Rpgrip1l hypomorphism induced in the adult CNS using tamox-
ifen-induced Nestin-Cre results in increased body weight and increased fat mass associated with increased 
food intake (8). To further refine the brain regions responsible for the increased food intake, we stereotaxically 
injected Cre recombinase–expressing adeno-associated viral particles (Cre-AAV) or GFP-expressing AAV 
(GFP-AAV) into the ARH of 12-week-old male Rpgrip1lfl/fl mice (Figure 1A). The mouse cohorts injected 
in the ARH were also compared with littermates that were targeted with Cre-AAV in both the dorsomedial 
(DMH) and ventromedial (VMH) hypothalami. By 16 weeks of  age, ARH expression of  Rpgrip1l in Cre-
AAV–injected mice was decreased by ~90%; these mice were ~50% heavier than animals in which Cre-AAV 
had been injected in the DMH + VMH or mice GFP-AAV–injected in the ARH (Figure 1, B and C). The 
increase in body weight in mice injected with Cre-AAV in the ARH compared with mice injected with GFP-
AAV in the ARH was due to an ~3-fold increase in fat mass (Figure 1, C and D). These findings suggest that 
effects of  Rpgrip1l on body weight are conveyed, in part, via the ARH in adult animals and that Rpgrip1l 
hypomorphism induced in the DMH + VMH of adult animals has no impact on adiposity.
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Cerebellar stereotaxic injections. Because RPGRIP1L mutations in JBST patients result in cerebellar vermis 
hypoplasia/aplasia (24), we stereotaxically injected Cre-AAV into the developing cerebellar vermis of  P10 
male Rpgrip1lfl/fl mice (Figure 2A). At P10, the cerebellar vermis is still under development (25). Similar to the 
DMH + VMH, Rpgrip1l hypomorphism in the cerebellar vermis did not increase adiposity in mice fed regular 
chow or a high-fat diet (Figure 2B). These data indicate that cerebellar Rpgrip1l may not be implicated in the 
regulation of  food intake.
Adult-onset Rpgrip1l hypomorphism specifically in Pomc neurons does not cause 
adiposity
We have reported that 16-week-old mice congenitally hypomorphic for Rpgrip1l in Pomc-expressing 
neurons (Rpgrip1l–/–[Pomc]) are obese due to increased food intake (8). However, tamoxifen-induced loss 
of  Rpgrip1l in terminally differentiated Pomc neurons in adult animals (Rpgrip1l–/–[adult Pomc–CreER]) at 8 
weeks of  age did not cause significant increases in body weight (Figure 3). In contrast, systemic Rpgrip1l 
loss (Rpgrip1l–/–[adult Cagg–CreER]) induced in adults phenocopies the obesity observed in Rpgrip1l–/–(Pomc) mice 
(Figure 3). These findings suggest that the developmental impact of  Rpgrip1l hypomorphism on Pomc 
neurons is the sole driver for the increased adiposity in Rpgrip1l–/–(Pomc) mice.
Congenital Rpgrip1l hypomorphism in Pomc neurons alters Pomc and Npy neuron number
Pomc-GFP–positive adult neuron number assessed by IHC. We hypothesized that congenital Rpgrip1l–/–(Pomc) mice 
may have reduced numbers of  POMC ARH neurons. In 10 μm coronal sections spanning the ARH of  
adult male Rpgrip1l–/–(Pomc) mice segregating for the Pomc-GFP transgene, we found that the number of  
GFP-positive ARH neurons is reduced by ~50% (Figure 4A).
Cell death of  Pomc neurons assessed by TUNEL. We examined the possibility that Rpgrip1l deletion in Pomc 
neurons leads to increased cell death. By TUNEL staining, we were unable to detect increased cell death 
in the developing hypothalamus of  Rpgrip1l–/–(Pomc) E11 embryos (when Pomc expression is initiated) or 
by induced Rpgrip1l deletion in Nestin-expressing adult hypothalamic neurons (Supplemental Figure 1; 
supplemental material available online with this article; https://doi.org/10.1172/jci.insight.123337DS1). 
These findings suggest that congenital Rpgrip1l hypomorphism does not cause cell death.
Pomc progenitor neuron number assessed by iDISCO. Using the brain-clearing iDISCO system and IHC, we 
quantified the number of  Pomc-expressing ARH neurons of  Rpgrip1l–/–(Pomc) mice at E13 when the numbers 
of  Pomc ARH progenitors are in highest (26, 27). We noted an ~20% decrease in Pomc-expressing ARH 
cells in Rpgrip1l–/–(Pomc) mice (Figure 4, B and C).
Pomc ARH-PVH projections assessed by IHC. We also utilized the mT/mG allele (28) in which the mem-
brane-bound tdTomato (mT) marker is globally expressed in all tissues except those Pomc-Cre–expressing 
cells in which recombination results in silencing of  mT and expression of  membrane-bound GFP (mGFP), 
allowing visualization of  cell bodies, projections, and terminals. We noted a marked increase in the density 
of  anterior medial hypothalamic projections to the paraventricular hypothalamus (PVH) in Rpgrip1l–/–(Pomc) 
and Rpgrip1fl/–(Pomc) mice (Figure 4, D and E).
Npy-positive adult neuron number assessed by IHC. Bbs2- or Bbs6-null obese mice (murine models of  the 
Bardet-Biedl ciliopathy) have an ~20% reduction in mature Pomc ARH neurons, as assessed by an anti-
Pomc antibody (29). In contrast, in our congenital Rpgrip1l–/–(Pomc) mice, the Pomc-GFP transgene marks 
mature Pomc neurons that actively express GFP, as well as ARH neurons derived from Pomc-expressing 
early developmental progenitors (e.g., Npy neurons; refs. 26, 27). Pomc is expressed by the majority of  
cells in the developing ventral hypothalamus at E10–E11 and is silenced later in gestation in more than 
half  of  these cells, some of  which become Npy neurons and some of  which are directed to other terminal 
fates (26, 27). Therefore, the adiposity and hyperphagia of  congenital Rpgrip1l–/–(Pomc) mice may be due 
to developmental changes in both mature Pomc ARH neurons and Pomc-derived ARH neurons. We 
explored the possibility that Rpgrip1l hypomorphism in Pomc neurons affected the number of  Npy-ex-
pressing neurons that derive from Pomc-expressing progenitors. The total number of  Npy-GFP–posi-
tive ARH neurons is increased by ~12% in Rpgrip1l–/–(Pomc) adult mice due to an ~2-fold increase in the 
number of  Npy neurons in the rostral ARH of  Rpgrip1l–/–(Pomc) mice (Figure 5). Respective increases and 
decreases of  hypothalamic Pomc and Npy neurons have been implicated in hypophagia (30, 31). The 
converse changes in the congenital Rpgrip1l–/–(Pomc) mice are consistent with their hyperphagia.
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Diminished ciliation of iPSC-derived neurons of patients with RPGRIP1L mutations
Generation of  iPSCs from JBST patients. We and others have demonstrated that Sonic Hedgehog (SHH) 
signaling activation promotes human stem cell differentiation to ARH-type neurons that predomi-
nately express POMC (70%–80%) and exhibit other hypothalamus-specific patterns of  gene transcrip-
tion (32–34). We generated iPSCs from three JBST patient primary skin fibroblast lines UW15 (35), 
UW04-03 (36), and UW04-04 (17) with biallelic mutations in the RPGRIP1L C2 domain that severely 
disrupt — or are predicted to disrupt — nephrocystin-4 binding that facilitates recruitment of  other 
proteins to the base of  the cilium (37). The iPSCs expressed the expected pluripotency markers (Sup-
plemental Figure 2). Pluripotency was further confirmed by injection of  the iPSCs into immunocom-
promised NOD scid γ (NSG) mice resulting in the formation of  teratomas that display ectodermal, 
mesodermal, and endodermal structures (Supplemental Figure 3A). The derived iPSCs had normal 
karyotypes (Supplemental Figure 3B).
Generation of  JBST neurons from iPSCs. We attempted to generate ARH-like neurons from the JBST 
iPSCs but were unable to generate NKX2.1-positive neuronal progenitors from which POMC and NPY 
neurons derive (38, 39), further suggesting the importance of  RPGRIP1L in the development of  ARH 
neurons. Subsequently, we utilized a dual-SMAD inhibition protocol (40) to direct differentiation of  the 
JBST iPSCs into neurons positive for neuromarkers Nestin, neuron-specific class III β-tubulin (TUJ1), and 
Neurofilament (NF) (Supplemental Figure 3C).
Figure 1. Adult-onset ARH Rpgrip1l deletion increases adiposity. (A) Stereotaxic injections of Cre-GFP–expressing AAV in the ARH (Rpgrip1lfl/fl;Cre-GFP;ARH) 
or Cre-expressing AAV particles in the DMH and VMH (Rpgrip1lfl/fl;Cre-GFP;DMH+VMH) of male mice. Scale bars: 1 mm. (B) Decreased Rpgrip1l expression in the 
ARH of Rpgrip1lfl/fl;Cre-GFP;ARH (n = 6) and in the DMH/VMH of Rpgrip1lfl/fl;Cre-GFP;DMH+VMH mice (n = 5). Rpgrip1l expression is indistinguishable in the ARH, 
DMH, or VMH of mice stereotaxically injected with GFP-expressing in the ARH (Rpgrip1lfl/fl;GFP;ARH; n = 6). P < 0.05 was statistically significant, by 1-way ANO-
VA. (C) Increased body weight and fat mass in Rpgrip1lfl/fl;Cre-GFP;ARH mice. P < 0.05 was statistically significant, by 1-way ANOVA. (D) Mass increase of various 
fat depots of Rpgrip1lfl/fl;Cre-GFP;ARH mice compared with Rpgrip1lfl/fl;GFP;ARH mice. Data in B, C, and D are represented as box-and-whisker plots; boxes are 
the interquartile range, lines are the median value, and whiskers are minimum and maximum values. *P < 0.01, by 2-tailed Student’s t test.
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Ciliation in iPSC-derived JBST neurons. ARL13B is a small GTPase that participates in ciliary formation 
and function (41). About 60% of  control neurons and ~40% of  JBST neurons were ARL13B-positive (Fig-
ure 6, A–C). ARL13B, IFT20, and IFT88 mRNA levels were indistinguishable between control and JBST 
neurons (Figure 6D), suggesting that the ~30% decrease in ARL13B-positive JBST neurons is due to lack 
of  cilia. No differences were observed in ciliary length between JBST and control neurons (Figure 6E).
RPGRIP1L hypomorphism is associated with perturbed SHH signaling
SHH conveys important hypothalamic neurospecification signals in vitro (32); these are mediated via the 
primary cilium (39, 42). When SHH binds to its receptor, PATCHED1, the liganded receptor exits the 
primary cilium, promoting ciliary entry of  Smoothened (SMO) and consequential upregulation of  down-
stream effectors, such as GLI1 (43), and negative feedback upregulation of  Patched1 (44).
Shh signaling in Pomc progenitors. Since Shh signaling is diminished in the neural tube of  E10 and E10 
embryos deleted for Rpgrip1l (18), we tested the possibility that Shh signaling in the ARH is perturbed by 
Rpgrip1l hypomorphism. In the developing hypothalamus of  Rpgrip1l–/–(Pomc) E13 embryos, ~15% of  Pomc 
neuroprogenitors were Smo-positive compared with ~35% in Rpgrip1lfl/fl control embryos (Figure 7A).
SHH signaling in JBST fibroblasts and iPSC-derived JBST neurons. In JBST human fibroblasts, SMO failed 
to localize to the primary cilium upon SHH exposure (Figure 7B). In iPSC-derived JBST neurons, AC3 
expression was decreased by ~60% and was ectopically localized in the neuron cell body rather than the 
Figure 2. Cerebellar Rpgrip1l hypomorphism has no effect on energy balance. (A) Stereotaxic injection of P10 male mice at the cerebellar vermis with Cre-
GFP–expressing AAV particles (Rpgrip1lfl/fl;Cre-GFP;VERMIS; n = 7) resulted in an ~85% decrease in Rpgrip1l expression compared with mice injected at the 
cerebellar vermis with GFP-expressing AAV particles (Rpgrip1lfl/fl;GFP;VERMIS; n = 8). Scale bar: 100 μm. (B) No difference in total body weight, fat mass, 
or lean mass between Rpgrip1lfl/fl;Cre-GFP;VERMIS and Rpgrip1lfl/fl;GFP;VERMIS male mice on ad lib regular chow up to 7 weeks of age or after 2 weeks on 
high-fat diet. Data in A are represented as box-and-whisker plots; boxes are the interquartile range, lines are the median value, and whiskers are minimum 
and maximum values. *P < 0.01, 2-tailed Student’s t test.
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primary cilium upon SHH stimulation (Figure 7C). Finally, upregulation of  PATCHED1 and GLI1 expres-
sion by ~40% and ~90%, respectively, after SHH treatment in control iPSC-derived neurons, was blunted in 
iPSC-derived JBST neurons (Figure 7D), further suggesting aberrant SHH signaling.
Alleles at rs1421085/rs8050136 and RPGRIP1L expression correlate with human embryonic 
stem cell–derived (ESc-derived) POMC-positive ARH neuron number
Obesity-associated SNPs in FTO intron 1, rs8050136 and rs1421085, are embedded within 2 binding sites 
for CUX1 (8). Based on electrophoretic mobility shift assays (7, 11), the rs8050136 A (risk) and rs1421085 
C (risk) alleles preferentially bind CUX1 isoform P200, whereas rs8050136 C (protective) and rs1421085 
T (protective) alleles preferentially bind CUX1 isoform P110. Luciferase-based promoter probing of  the 
rs8050136 and rs1421085 genomic regions in hypothalamus-derived N2a cells, and systemic overexpres-
sion of  Cux1 isoforms p200 and p110 in vivo (8, 17), implicate P200 as a repressor of  Fto and P110 as an 
activator of  Rpgrip1l expression in the CNS.
Alteration of  rs8050136 and rs1421085 by CRISPR. Using the human H9 ESc line that is heterozygous 
for rs8050136 and rs1421085 risk alleles, we have used Clustered Regularly Interspaced Short Palindrom-
ic Repeats (CRISPR)/CRISPR-associated protein-9 (Cas9) technology to create an isogenic allelic series 
for the adiposity risk (R) or protective-associated (P-associated) alleles at SNP rs8050136 or rs1421085 in 
human ESc–derived ARH neurons (Supplemental Figure 4A) (45). We have confirmed that these lines are 
correctly targeted, karyotypically normal, and display no apparent off-target effects (45).
FTO/RPGRIP1L expression per rs8050136/rs1421085 allele in isogenic ARH neurons. Homozygosity for the risk 
allele at rs8050136 or rs1421085 resulted in respective ~45% and ~75% decreases in generation of ARH-type 
neurons compared with neurons homozygous for the protective allele at rs8050136 or rs1421085 (Figure 8A). 
Homozygosity for the risk allele at rs8050136 or rs1421085 correlated with an ~20%–30% decrease in FTO or 
RPGRIP1L expression in ARH-type neurons (Figure 8B).
POMC neuron number per rs8050136/rs1421085 allele in isogenic ARH neurons. Homozygosity for the risk 
allele at rs8050136 or rs1421085 was associated with an ~30% decrease in POMC-positive neurons (Figure 
8C) compared with neurons homozygous for the protective allele at rs8050136 or rs1421085.
Figure 3. Rpgrip1l loss in adult Pomc neurons has no effect on body weight. (A and B) Loss of Rpgrip1 at 8 weeks of age 
in both (A) male and (B) female adult POMC neurons (Rpgrip1l–/–[adult POMC–CreER]; n = 4 male [♂] and n = 5 female [♀]) did not 
result in obesity compared with littermate controls (Rpgrip1l[adult POMC–CreER Control]; n = 9♂ and n = 7♀). In contrast to obese sys-
temic Rpgrip1l loss (Rpgrip1l–/–[adult Cagg–CreER]; n = 5♂ and n = 4♀) compared with littermate controls (Rpgrip1l[adult Cagg–CreER Control]; 
n = 4♂ and n = 7♀). *P < 0.05 using 2-tailed Student’s t test.
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FTO/RPGRIP1L expression per rs8050136/rs1421085 allele in isogenic ARH neurons overexpressing P200. We 
overexpressed CUX1 P200 at day 26 of the differentiation protocol, which is 1 day before differentiating cells 
normally initiate expression of POMC (32, 34) (Claudia Doege, Columbia University, personal communica-
tion). P200 overexpression by lentiviral transduction of ARH neurons homozygous for the risk allele (preferen-
tially bound by P200) at rs8050136 or rs1421085 decreased FTO expression by ~60% (Figure 8B). P200 over-
expression also resulted in increased P110 protein levels (Supplemental Figure 4, B and C), presumably due 
to constitutive Cathepsin L processing of P200–P110 (7). Increased P110 protein levels in neurons homozy-
gous for the risk alleles at rs8050136 or rs1421085 were associated with an ~20%–30% increase in RPGRIP1L 
expression (P = 0.06), presumably due to the lower DNA-binding affinity of P110 for the risk alleles (7).
POMC neuron number per rs8050136/rs1421085 obesity-risk allele in isogenic ARH neurons overexpress-
ing P200. The increase in RPGRIP1L expression in ARH neurons homozygous for the risk alleles at 
rs8050136 or rs1421085 overexpressing P200 was associated with restoration of  POMC-positive neuron 
number (Figure 8C). Furthermore, RPGRIP1L overexpression (~2-fold) by lentiviral transduction of  
neurons homozygous for the obesity-risk allele at rs1421085 was associated with an ~50% increase in the 
number of  POMC-positive neurons (Figure 8C).
Figure 4. Neurostructural changes in mice congenitally deleted for Rpgrip1l in Pomc neurons. (A) Decreased number of GFP-positive ARH neurons in 
Rpgrip1l–/–(Pomc) male mice (n = 4) compared with Rpgrip1lfl/fl mice (n = 6) segregating for the Pomc-GFP allele. Scale bar: 40 μm. (B) Sagittal view of whole E13 
Rpgrip1l–/–(Pomc) and Rpgrip1lfl/fl mouse embryo heads cleared with iDISCO after immunostaining for GFP. Dotted circle indicates ARH Pomc neuroprogenitor 
localization. Scale bar: 500 μm. (C) Decreased number of Pomc progenitors in Rpgrip1l–/–(Pomc) (n = 5) compared with Rpgrip1lfl/fl embryos (n = 5) assessed 
by IHC and brain clearing. (D) Coronal sections of the PVH showing allele dose–dependent increase in GFP-positive PVH projections in mice congenitally 
deleted for 1 (Rpgrip1lfl/–(Pomc)) (n = 5) or 2 (Rpgrip1l–/–(Pomc)) (n = 5) Rpgrip1l alleles compared with Rpgrip1lfl/fl control mice (n = 6). Mice also carried the mT/mG 
allele. PVH projections are marked with mGFP. mTomato marks all other cells. Scale bar: 500 μm. P < 0.05 was statistically significant, by 1-way ANOVA. 
(E) Three-dimensional reconstruction from a stack of 40-μm coronal sections covering the whole PVH and part of the ARH in a 6-week Rpgrip1l–/–(Pomc) and 
Rpgrip1lfl/fl mouse showing increased PVH projections and decreased ARH mGFP-positive cells. Data in A, C, and D are represented as box-and-whisker plots; 
boxes are the interquartile range, lines are the median value, and whiskers are minimum and maximum values showing increased PVH projections and 
decreased ARH mGFP-positive cells. Scale bar: 100 μm (E). *P < 0.04, **P < 0.01, by 2-tailed Student’s t test.
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Fto does not affect Pomc neuron number. Because (a) RPGRIP1L overexpression alone is sufficient to increase 
POMC neuron number and (b) the increase in RPGRIP1L expression and decreased FTO expression upon 
P200 overexpression restores POMC number in neurons homozygous for the risk alleles at rs8050136 or 
rs1421085, it is implied that RPGRIP1L is important for POMC neuron specification and that FTO protein 
does not participate in the differentiation of POMC neurons. In support of the latter inference, mice homozy-
gous for the Fto-floxed allele (Ftofl/fl) (8) and also segregating for Pomc-Cre and Pomc-GFP have no apparent 
change in the number of adult GFP-positive neurons compared with Ftofl/fl littermates (Supplemental Figure 5).
Discussion
The hyperhagia and obesity caused by induced Rpgrip1l deletion in the terminally differentiated CNS (8) (Fig-
ure 1) supports the importance of Rpgrip1l in the maintenance and/or neurochemical function of the devel-
oped feeding neurocircuitry. It is likely that diminished leptin sensitivity is partly responsible for the increased 
energy intake. The fact that adult-onset Rpgrip1l deletion in Pomc neurons did not result in increased body 
weight implies that Rpgrip1l is not essential for the neurochemical function of Pomc adult neurons. Instead, 
the data presented here support a critical role of RPGRIP1L in the development of Pomc-expressing neuropro-
genitors, including Npy neurons that derive from Pomc-expressing progenitors (26, 27). The reciprocal decrease 
in anorexigenic Pomc neurons and increase in orexigenic Npy neurons may provide a cellular anlage for the 
hyperphagia of Rpgrip1l–/–(Pomc) mice. Our finding that POMC neuron specification can be altered by modulating 
RPGRIP1L expression per genotype at obesity risk alleles at rs1421085 or rs8050136 supports the relevance of  
this mechanistic formulation to the adiposity highly associated with allelic variation at these FTO intronic loci.
Figure 5. Increased numbers of hypothalamic Npy neurons in male mice congenitally deleted for Rpgrip1l in Pomc neurons. Increased number of Npy 
neurons in the rostral and whole ARH of 6-week Rpgrip1l–/–(Pomc) mice (n = 9) compared with Rpgrip1lfl/fl control mice (n = 6) also segregating for the Npy-GFP 
allele. Scale bar: 100 µm. Data are represented as box-and-whisker plots; boxes are the interquartile range, lines are the median value, and whiskers are 
minimum and maximum values. *P <0.04, **P < 0.01, by 2-tailed Student’s t test.
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The Pomc-GFP transgene that we used also necessarily marks those neurons that develop from Pomc-ex-
pressing neuroprogenitors. We anticipate that specific neuronal subpopulations are affected by Pomc-specific 
congenital deletion of  Rpgrip1l. However, with the exception of  Npy neurons — some of  which are known 
to develop from Pomc precursors — we have not identified these neuronal subpopulations. Therefore, the 
precise neurocellular consequences of  the congenital interference with Rpgrip1l expression in Rpgrip1l–/–(Pomc) 
mice are not known. Future work should be directed toward identifying all the ARH neuronal subpopu-
lations affected in Rpgrip1l–/–(Pomc) mice, as well as assigning the affected ARH-PVH projections to specific 
ARH neuronal subpopulations.
The increase in PVH projections emanating from the ARH of  Rpgrip1l–/–(Pomc) mice may partly reflect 
the increase in the number of  Npy neurons. However, the large magnitude of  the increase in projections, 
and the relatively smaller magnitude in increase of  Npy number in Rpgrip1l–/–(Pomc) mice, suggests that other 
ARH neurons that derive from Pomc-expressing progenitors are also affected. Alternatively, Rpgrip1l hypo-
morphism may relieve inhibition of  axon growth/guidance (46) leading to this apparent change in wiring 
of  the feeding neurocircuitry.
Using a hypothalamic differentiation protocol reported elsewhere (32, 34), the human H9 ESc line and 
“CRISPERed” isogenic lines produced 70%–80% POMC-positive neurons, whereas less than 1% of  ARH 
neurons were NPY positive. By E18, more than half  of  POMC neurons convert to NPY-positive neurons 
during embryogenesis (26). We believe that the differentiation protocol employed here gives rise to early 
Figure 6. Reduced ciliogenesis in human neurons with hypomorphic mutations of RPGRIP1L. (A) Scanning microscopy of iPSC-derived Joubert Syndrome 
patient (JBST) and control neurons. Red arrow indicates a primary cilium. The iPSC-derived JBST neuron lacks a primary cilium. Scale bar: 1 μm. (B) Immu-
nostaining showing decreased number of cilia positive for ARL13B in JBST neurons. MAP2 is a neuronal marker, and γ-tubulin marks the basal body. Scale 
bar: 20μm. (C) Decreased percentage of ARL13B-positive JBST neurons. Each dot represents 500 neurons. (D) mRNA levels of ARL13B and ciliary structural 
genes IFT20 and IFT88 are indistinguishable between control and JBST neurons. Each dot represents 1 cell line. Expression normalized to TATA box binding 
protein (TBP). (E) No difference in ARL13B-positive ciliary axonemal length between control and JBST neurons. Each dot represents the average of 500 
neurons. *P < 0.01, by 2-tailed Student’s t test.
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POMC progenitors that may resemble those at E13 in the mouse in vivo. The decreased POMC cell number 
in the human ESc–derived ARH neurons segregating for the obesity risk alleles at rs1421085 or rs8050136 is 
in agreement with the reduction in Pomc neuroprogenitors in Rpgrip1l–/–(Pomc) embryos at stage E13.
We were unable to detect any increase in cell death in Rpgrip1l–/–(Pomc) or control embryos at E11 when 
Pomc expression turns on in the developing hypothalamus; cell death in the ARH is not common at this 
developmental stage (Lori Zeltser, Columbia University; personal communication). Similarly, adult-onset 
Rpgrip1l deletion in the CNS using Nestin-Cre did not increase cell death in the adult ARH. It is possible that 
we have missed a narrow time window at which increased apoptosis may have occurred in Rpgrip1l–/–(Pomc) 
neurons. Ex vivo live imaging of  Pomc progenitors at the developmental stage when POMC expression 
is normally initiated might provide insights into this issue. However, the fact that Npy neuron number 
increased in the adult ARH of  Rpgrip1l–/–(Pomc) mice suggests a cell specification–related phenotype. More-
over, the human fibroblasts with biallelic mutations in RPGIRP1L used in this study proliferate at normal 
rates, suggesting that perturbed RPGRIP1L function does not promote apoptosis.
An important question is whether RPGRIP1L hypomorphism causes proliferative and/or cell fate specifi-
cation changes in POMC-expressing progenitors or neurons that derive from them. RPGRIP1L, a component 
Figure 7. Sonic Hedgehog (SHH) signaling is impaired in JBST patient fibroblasts and neurons. (A) IHC showing decreased Smo-positive Pomc-expressing 
neuroprogenitors (green, Pomc-GFP) in E13 Rpgrip1l–/–(Pomc) (n = 3) compared with Rpgrip1lfl/fl embryos (n = 3). Scale bars: 10 μm. (B) Immunostaining of 
Smoothened (SMO) and Acetylated-tubulin (Ac-Tub) showing that JBST fibroblasts fail to translocate SMO to the cilium upon SHH stimulation (100 ng/ml).  
Scale bar: 5μm. Arrow indicates primary cilium. (C) Diminished AC3 expression and localization in the ciliary axoneme of iPSC-derived JBST neurons in the 
absence of SHH. SHH stimulation resulted in ectopic AC3 localization in the neuron cell body in iPSC-derived JBST neurons. Neuron cell body and projec-
tions are also marked with neuro-specific markers Neurofilament (NF) and NeuN. Each column represents the average of 3 cell lines. Scale bar: 100 μm. (D) 
PATCHED1 and GLI1 expression is not increased in iPSC-derived neurons from JBST patients UW04-03 and UW04-04 upon SHH stimulation. Each column 
represents the average of 3 cell lines. Expression was normalized to the TATA box binding protein (TBP). *P < 0.01, by 2-tailed Student’s t test.
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of the centrosome, and CUX1 are implicated in the control of  the cell cycle (47, 48), a cellular process coordi-
nated with ciliary formation arising from the centrosome and ciliary disassembly (49). Nevertheless, it is not 
clear whether the primary cilium regulates cell division. On the other hand, the importance of  the primary cil-
ium in the control of  SHH signaling and neuropatterning is well established (42). Shh signaling is disrupted in 
systemic Rpgrip1l-null embryos in which CNS structural abnormalities are prominent (18, 50). We conclude 
that RPGRIP1L regulates Pomc neuron specification by a SHH-dependent mechanism.
The primary cilium is also involved in cell migration. The platelet-derived growth factor receptor α (PDG-
Frα) localizes to the primary cilium and is part of  the PDGF signaling pathway that controls cell migration 
during development and in the adult via AKT signaling and mammalian target of  rapamycin complex 1 
(mTORC1) pathways (51, 52). RPGRIP1L has been implicated in the mTORC1 pathway (53), and Rpgrip1l 
hypomorphism results in perturbed neuronal migration of  the murine developing cortex (20). The potential 
effects of  Rpgrip1l hypomorphism on Pomc-neuron migration during development, as well as potential effects 
on neuronal function of  Pomc neurons and other neuronal subpopulations affected, are areas of  interest.
Pomc is expressed in other sites implicated in feeding behavior, such as the pituitary and brain stem (54, 
55), and Pomc neurons in the ARH project to other brain regions, such as the dorso vagal complex (55). 
Figure 8. Obesity-risk alleles in FTO intron 1 diminish RPGRIP1L expression and POMC differentiation. (A) Decreased neuro-confluency of human ESc–
derived isogenic ARH neurons (day 30) homozygous for the FTO risk (R/R) allele at rs1421085 or rs8050136 compared with neurons homozygous for the 
protective (P/P) allele at rs1421085 or rs8050136. Scale bar: 20 μm. (B) Decreased FTO and RPGRIP1L expression in ARH neurons derived from the human 
H9 ESc line CRISPRed to homozygosity for the risk allele at rs1421085 or rs8050136. P < 0.05 was statistically significant, by 1-way ANOVA. (C) Upregulation 
of RPGRIP1L expression in response to increased P110 protein levels secondary to P200 overexpression (Supplemental Figure 4B), or in response to virus-
induced RPGRIP1L overexpression, correlated with increased POMC neuron number. Red letters signify CRISPRed alleles. Each column represents the 
average of 6 isogenic cell lines. Data in A, B, and C are represented as box-and-whisker plots; boxes are the interquartile range, lines are the median value, 
and whiskers are minimum and maximum values. *P < 0.05, **P < 0.04, ***P < 0.01, by 2-tailed Student’s t test.
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Therefore, Rpgrip1l hypomorphism may affect Pomc number and projections in other regions in a manner 
similar to the ARH.
A recent study indicates that the melanocortin 4 receptor (MC4R) is located on the primary cilium 
and that hypomorphic Mc4r mutations impair the receptor’s ciliary trafficking in PVH neurons (56). In the 
same study, inhibition of  ciliary Ac3 in Mc4r-expressing neurons was associated with obesity. Shh reduces 
cAMP levels in the primary cilium by inhibiting adenylyl cyclase activity (57). We observed decreased AC3 
(ADCY3) expression and ectopic AC3 localization upon SHH stimulation in JBST iPSC–derived neurons. 
It is plausible that upregulation of  AC3 expression in response to adenylyl cyclase inhibition by Shh in 
circumstances of  RPGRIP1L hypomorphism results in accumulation of  AC3 in the cell body due to the 
deranged AC3 trafficking. However, we find that Rpgrip1l hypomorphism suppresses adiposity in Ac3+/– 
mice, suggesting that RPGRIP1L is functionally downstream of  AC3 and that the AC3-mediated adiposity 
is not caused by RPGRIP1L hypomorphism (8). Therefore, it is unlikely that decreased AC3 expression 
and ectopic AC3 localization are driving the developmental defects caused by RPGRIP1L hypomorphism 
in Pomc neurons. On the other hand, AC3 and cAMP signaling mediate axon outgrowth and guidance in 
the CNS (58) and may be, at least in part, responsible for the perturbed Pomc neuron axonal outgrowth in 
circumstances of  RPGRIP1L deficiency.
Previous studies have produced conflicting results regarding the correlation of  allelic variations at 
the FTO intronic region with FTO expression or expression of  nearby genes. Smemo et al. (59) report-
ed higher expression of  iroquois homeobox 3 (IRX3) in human cerebellar and adipose tissue homozy-
gous for FTO obesity risk alleles at rs9930506 compared with tissue from individuals homozygous for 
the protective FTO alleles. In contrast, partial inhibition of  Irx3 in the murine hypothalamus has the 
opposite effect of  what would be predicted by the direction of  the association or by Irx3 global deletion 
(59, 60). Moreover, Claussnitzer et al. (61) failed to see an allele-specific effect on IRX3 expression in a 
hippocampal neuronal cell line, but they reported effects of  allelic variants at rs1421085 on IRX3 and 
-5 (IRX3/5) in preadipocytes. Claussnitzer et al. proposed a mechanism by which obesity risk alleles 
of  rs1421085 in human mesenchymal adipocyte progenitors increase expression of  IRX3/5, resulting 
in decreased thermogenic potential of  new adipocytes. However, a follow-up study presented in vivo 
and in vitro evidence that Irx3 positively regulates thermogenesis (62). The relevance of  these mech-
anisms in humans is unclear, as the effects of  the obesity-risk alleles in the first intron of  FTO have 
been consistently reported to convey effects on food intake and not energy expenditure (6, 63–71). 
The inconsistencies in correlation of  allelic variation to expression of  FTO and vicinal genes may be 
attributed to the possibility that different haplotypes within intron 1 affect different genes and, thereby, 
different physiological process. This possibility would be consistent with multiple mechanisms (72) 
at different levels of  penetrance and within different race/ethnicities, underlying such a statistically 
strong effect of  noncoding alleles on adiposity. The present study focuses on the action of  RPGRIP1L 
in neurons, in which expression of  RPGRIP1L, but not IRX3/IRX5, is correlated in an FTO intronic 
allele dose-dependent manner (8).
In summary, we present evidence that the very strong association with adiposity of  highly prevalent 
sequence variants in intron 1 of  FTO are due, in part, to their indirect impact on the primary cilium. Our 
data imply that genetic mediation of  nonsyndromic, prevalent obesity is conveyed partly by structural alter-
ation of  the hypothalamic cells and circuitry that mediate aspects of  ingestive behaviors.
Methods
Mouse studies. Rpgrip1lfl/fl, Pomc-Cre (The Jackson Laboratory; stock number 005965), Pomc-GFP (The Jack-
son Laboratory; stock number 009593), and Nestin-CreERT2 mice (The Jackson Laboratory; stock number 
016261) have been described by us elsewhere (8). The Cagg-CreER allele (Tg[CAG-cre/Esr1*]5Amc/J, The 
Jackson Laboratory, stock number 004682) used to assess systemic Rpgrip1l loss in adults was induced as 
previously reported (73). For adult-induced loss of  Rpgrip1l specifically in adult terminally differentiated 
POMC neurons, a POMC-CreER allele that has previously been described (74) was utilized. mT/mG mice 
were purchased from The Jackson Laboratory (B6.129[Cg]-Gt[ROSA]26Sortm4[ACTB-tdTomato,-EGFP]
Luo/J; stock number 007676). Npy-GFP mice were also purchased from The Jackson Laboratory (Npy-
GFP [C57BL/6JTgNPY-hrGFP]; stock number 006417). Ftofl/fl mice are described elsewhere (8). Mice 
where housed in a Barrier facility at room temperature (23°C) on a 12-hour light/12-hour dark cycle (lights 
off  at 7 p.m.), with ad libitum (ad lib) access to food and water.
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Human studies. UW15 (7), UW04-04 (17), and UW04-03 (36) primary skin fibroblast JBST lines were 
provided by Daniel Doherty (University of  Washington, Seattle, Washington, USA). ESc line H9 was pur-
chased by WiCell Research Institute Inc. (catalog WA09).
Diet and dietary treatment. All mice were fed regular chow (Purina Mills; Picolab, catalog 5058) (16) ad 
lib unless specified. High-fat diet consists of  65% of  calories as fat (catalog D12492; Open Source Diets).
Body mass and composition measurements. Measurements were taken with a Minispec TD-NMR Analyzer 
(Bruker Optics) as described elsewhere (8).
Isolation of  total RNA and nuclear protein extracts. Total RNA and protein extraction have been described 
elsewhere (17). Specific brain regions were micropunched as described in Stratigopoulos et al. (7).
Quantitative PCR (qPCR) and cDNA synthesis. The method has been described elsewhere (7). The geomet-
ric mean of  GAPDH and ACTB expression levels was used as loading controls, unless specified. The PCR 
primers used are shown in Supplemental Table 1.
IHC, immunofluorescence, and antibodies. IHC was performed on cryosections after perfusion fixa-
tion, as described elsewhere (17). Teratomas were embedded in paraffin and further cut into 8 μm–
thick sections. Sections were stained with H&E using a standard protocol (http://www.ihcworld.com/ 
_protocols/special_stains/h&e_ellis.htm). Cells growing on cultured-cell slides pretreated with Poly–L- 
ornithine/laminin were fixed with 4% paraformaldehyde for 10 minutes at room temperature. Prima-
ry fibroblasts were starved for 36 hours before visualization of  primary cilia by immunofluorescence. 
The following primary antibodies were used: anti-GFP (1:100; Abcam, catalog ab6662), TUJ1 (1:500; 
MilliporeSigma, catalogs T2200 and T5076), MAP2 (1:10,000; Abcam, catalog AB5392), AC3 (1:100; 
Santa Cruz Biotechnology Inc., catalog sc-588), ARL13B (1:1,000; gift from Tamara Caspary, Emory 
University, Atlanta, Georgia, USA), SMO (1:500; gift from Kathryn V. Anderson, Memorial Sloan Ket-
tering Cancer Center, New York, New York, USA), NF (1:10,000; MilliporeSigma, catalog AB5539), 
γ-tubulin (1:500; MilliporeSigma, catalog T6557), NESTIN (1:500; Stemgent, catalog 09-0045), NeuN 
(1:100; MilliporeSigma, catalog MAB377), Acetylated tubulin (1:500; MilliporeSigma, catalog T6793), 
POMC (1:500; Abcam, catalog ab14064), NPY (1:500; Novus, catalog npb1-19808), αMSH (1:500; 
MilliporeSigma, catalog AB5087), and Gad67 (1:500; MilliporeSigma, catalog MAB5406).
TUNEL. TUNEL staining was performed using the DeadEnd Fluorometric TUNEL System (Prome-
ga, catalog G3250) according to the manufacturer’s instructions.
Scanning electron microscopy. iPSC-derived neurons were grown on 13 mm glass coverslips and fixed in 
2.5% glutaraldehyde in 0.1 M Cacodylate buffer for 30 minutes at room temperature. Sample preparation 
and imaging for scanning electron microscope was done by the analytical imaging facility at Albert Einstein 
College of  Medicine (New York, New York, USA). Experimental details are described elsewhere (75). Images 
were obtained at 5000× magnification.
Brain clearing and imaging. For brain clearing, we followed the protocol described in great detail at 
https://idisco.info/idisco-protocol/. Briefly, signal was enhanced by treatment with anti-GFP antibody 
(Aves Laboratories, catalog GFP-1020) and secondary Alexa Fluor 647 (anti-chicken; Thermo Fisher 
Scientific, catalog A-21449), followed by dehydration performed with tert-Butanol. Delipidization was 
achieved by treatment with dichloromethane (DCM). Then, samples were stored overnight in Benzyl 
alcohol-Benzyl benzoate/Diphenyl ether (4:1 vol/vol; BABB-4D) before imaging. Whole E13 embryo 
heads were recorded with a light sheet fluorescent Ultramicroscope II (Lavision Biotech) utilizing the 
filters (emission/excitation; Em/Ex) 470/425 nm for tissue autofluorescence and 630/680nm for ampli-
fied GFP signal. ARH area was recorded in detail at 4× zoom with a 2-μm plane size. Cell counting was 
performed with Arrivis Vision4D software (Arrivis) after 3-dimensional (3-D) reconstruction, background 
removal and cell segmentation.
Viruses. Ready-to-transduce lentiviral particles carrying human CUX1 P200 (NM_181552) and 
RPGRIP1L (NM_015272) were purchased by ORIGENE. AAV1 particles used for stereotaxic injections 
(AAV1.CMV.PI.eGFP.WPRE.bGH, AAV1.CMV.HI.eGFP-Cre.WPRE.SV40) were purchased from the 
Penn Vector Core (University of  Pennsylvania, Philadelphia, Pennsylvania, USA).
Cerebellar stereotaxic injections. Male C57BL/6J mice aged P11 were anesthetized with a combination 
of  ketamine (80 mg/kg) and xylazine (12 mg/kg) (MilliporeSigma, catalog K113), administered i.p. Mice 
were then placed in a stereotaxic frame adapted for juveniles, and the scalp was clipped of  fur and ster-
ilized. A longitudinal incision was made through the scalp, and the skull was leveled. The target site for 
injection, defined as 2.6 mm caudal to lambda along the midline, was measured stereotaxically, and the 
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skull above the target was carefully drilled very thin. A glass micropipette loaded in a Drummond Nanoject 
III device was then filled with AAV1 and positioned over the target site. The pipette was lowered through 
the soft, thin skull into the cerebellum to a depth of  2.5 mm below the brain surface. Pulses of  20 nl each 
were injected at 2.5 mm, 2.0 mm, 1.5 mm, 1.0 mm, and 0.5 mm ventral to the brain surface, pausing for 1 
minute after each pulse before moving to other sites. Following retraction of  the pipette, the incision was 
closed and mice were permitted to recover from anesthesia prior to being returned to nursing dams.
ARH and DMH/VMH stereotaxic injections. Injections of  12-week-old male Rpgrip1lfl/fl mice were performed 
on a stereotaxic frame using a glass micropipette and an air pressure injector system (76, 77). Each animal 
was injected at 3 sites bilaterally for a total of  6 injections and a total volume of  ~150 nl to ensure complete 
coverage of  the ARH (mediolateral [ML], ±0.3 mm; anteroposterior [AP], –1.6 mm; dorsoventricular [DV], 
–6 mm) or DMH/VMH (ML, ±0.3; AP, –1.6; DV, –5.8mm). The accuracy of  injections was ~50%. Injec-
tions that missed the targeted regions did not result in body weight changes. These were excluded from the 
analysis but provide evidence of  the cellular specificity of  the phenotypic effects. All surgical procedures 
were performed using an aseptic technique according to the approved protocols at Columbia University.
Generation and characterization of  iPSCs. JBST primary fibroblasts were reprogrammed into iPSCs using 
retroviruses expressing cMYC, OCT4, SOX2, and KLF4 (78). All iPSCs lines were cultured on mouse 
embryonic fibroblast (MEF) cells with human ES medium: 500 ml KO DMEM (Thermo Fisher Scientific, 
catalog 10829018), 90 ml KO Serum (Thermo Fisher Scientific, catalog A3181502), 6.5 ml GlutaMAX 
(Thermo Fisher Scientific, catalog 35050061), 6.5 ml NEAA (Thermo Fisher Scientific, catalog 11140050), 
6.5 ml penicillin/streptomycin (Thermo Fisher Scientific, catalog 15140122), 0.65 ml β-mercaptoethanol 
(Thermo Fisher Scientific, catalog 21985023), and 10 ng/ml bFGF (Thermo Fisher Scientific, catalog 
13256029). Stable iPSC clones (after 8 passages) were characterized by immunostaining with pluripotency 
markers SOX2 (1:500; Stemgent, catalog 09-0024), OCT4 (1:500; Stemgent, catalog 09-0023), NANOG 
(1:500; R&D Systems, catalog AF1997), SSEA4 (1:300; R&D Systems, catalog MAB1435), and TRA-
1-60 (1:300; MilliporeSigma, catalog MAB4360), as well as by qPCR analysis to confirm retroviral gene 
silencing and expression of  endogenous pluripotency genes, as described elsewhere (Supplemental Figure 
2B) (32, 34). Pluripotency was further confirmed by a teratoma assay: JBST iPSCs (5 million/200μl matri-
gel) were injected s.c. into NSG mice (The Jackson Laboratory, NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ, cat-
alog 005557), and after 2–3 months, teratomas were isolated and fixed with 4% paraformaldehyde for >16 
hours for immunohistochemical analysis. For karyotyping, control and JBST iPSC lines were cultured in 
T75 flasks and karyotyped by Cell Line Genetics.
Neuron differentiation protocols. Human iPSCs were cultured and maintained in human ESc medium on 
MEF (111,000 cells/well in 6-well plates; Thermo Fisher Scientific, catalog A34180). Upon confluence, iPSC 
cells were cultured for 4 days in EB medium (human ESc medium without basic fibroblast growth factor 
(bFGF) plus dual SMAD inhibitors — A83 (1 μM; Stemgent, catalog 04-0014) and LDN (250 nM; Stemgent, 
catalog 04-0074). From days 5–8, EB medium was replaced with N2 medium in steps from 75% to 50%, 
to 25%, and to 0%, while maintaining A83 and LDN at constant concentrations. Neuron progenitors were 
harvested on day 10 and further expanded for 2–3 passages in N2 medium plus A83/LDN on poly–L-orni-
thine/Laminin–coated plates. For further neuronal differentiation, cells were cultured on Poly–L-ornithine/
Laminin–coated plates (Thermo Fisher Scientific, catalog 08-772-66) at 50,000 cells per 24-well or 4-well plate 
and at 500,000 cells per 6-well plate. After culturing 3 weeks in N2 medium supplemented with B27 (Ther-
mo Fisher Scientific, catalog 17504044), DAPT (10 μM; Stemgent, catalog 04-0041), and BDNF (20 ng/ml; 
R&D Systems, catalog 248-BD), neurons were fixed/harvested for IHC or RNA analysis.
H9 and H9-derived isogenic lines were differentiated to ARH neurons following the detailed protocol 
described in a Methods manuscript by Wang et al. (34).
CRISPR. The H9 ES cell line was propagated and subjected to CRISPR as extensively described else-
where (45). Six isogenic lines per genotype were used for analysis.
Three-dimensional reconstructions of  the PVH/ARH. We utilized the Zeiss Axio Scan.Z1 (Baymax) auto-
mated slide scanner to visualize nuclei by DAPI (Zeiss Filter Set 49), as well as mGFP-positive (FS 38 HE) 
Pomc neurons and their projections in 60 μm coronal sections spanning the whole PVH and ARH. Images 
were aligned in Adobe Photoshop; Z-stacks were generated in ImageJ (NIH) and reconstructed in 3-D 
using Vaa3D (https://github.com/Vaa3D) and CamStudio (www.camstudio.org).
Statistics. Data are expressed as means ± SEM unless specified. Statistical analysis was performed using 
2-tailed Student’s t test (StatView 5.0, SAS Institute Inc.). Statistical significance of  the difference between 
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3 means was determined by 1-way ANOVA using GraphPad Prism 7. Levels of  statistical significance were 
set at P < 0.05.
Study approval. Animals were maintained according to Columbia University animal welfare guidelines. 
All procedures were approved by the Columbia University IACUC. Human subjects provided written 
informed consent, and human subject–related research was reviewed and approved by the Columbia Stem 
Cell Committee and the Columbia IRB.
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